BDBM207869 US9266832, Cpd026
SMILES: Clc1ccc2[nH]cc(CCNC(=O)c3ccc(CNCc4cccs4)cc3)c2c1
InChI Key: InChIKey=ARAIOWFKWHCOKE-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpha-synuclein (Homo sapiens (Human)) | BDBM207869 (US9266832, Cpd026) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 83 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair |